Game-changing drugs for people with lung cancer.

Pharmac has announced its funding of Keytruda and Tecentriq.

Those with locally advanced and metastatic non-small cell lung cancer are able to access it from next month.

The disease is the leading cause of cancer-related deaths in New Zealand.

Director of operations Lisa Williams told Mike Hosking there hasn't been treatment for lung cancer in New Zealand like this.

She says they're a new kind of immune checkpoint inhibitors, which will benefit around 700 people each year.

LISTEN ABOVE